338 related articles for article (PubMed ID: 9673796)
41. Proglumide exhibits delta opioid agonist properties.
Rezvani A; Stokes KB; Rhoads DL; Way EL
Alcohol Drug Res; 1987; 7(3):135-46. PubMed ID: 3030338
[TBL] [Abstract][Full Text] [Related]
42. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
43. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
44. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
Chavkin C; James IF; Goldstein A
Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
[TBL] [Abstract][Full Text] [Related]
45. 6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptors.
Xu H; Goodman CB; Partilla JS; Ni Q; Kayakiri H; Rice KC; Rothman RB
Synapse; 1995 Feb; 19(2):105-11. PubMed ID: 7725239
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.
Tan-No K; Cebers G; Yakovleva T; Hoon Goh B; Gileva I; Reznikov K; Aguilar-Santelises M; Hauser KF; Terenius L; Bakalkin G
Exp Cell Res; 2001 Sep; 269(1):54-63. PubMed ID: 11525639
[TBL] [Abstract][Full Text] [Related]
47. Delta and kappa opioid receptors in the rabbit ear artery.
Berzetei IP; Fong A; Duckles SP
NIDA Res Monogr; 1986; 75():105-8. PubMed ID: 2828953
[TBL] [Abstract][Full Text] [Related]
48. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
[TBL] [Abstract][Full Text] [Related]
49. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
Goldstein A; James IF
Mol Pharmacol; 1984 May; 25(3):343-8. PubMed ID: 6328260
[TBL] [Abstract][Full Text] [Related]
50. N,N-diallylated analogs of dynorphin A-(1-13) as potent antagonists for the endogenous peptide and selective kappa opioid analgesics.
Lemaire S; Parent P; Lapierre C; Michelot R
Prog Clin Biol Res; 1990; 328():45-8. PubMed ID: 1968273
[No Abstract] [Full Text] [Related]
51. Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivity.
Bertha CM; Ellis M; Flippen-Anderson JL; Porreca F; Rothman RB; Davis P; Xu H; Becketts K; Rice KC
J Med Chem; 1996 May; 39(10):2081-6. PubMed ID: 8642567
[TBL] [Abstract][Full Text] [Related]
52. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
[TBL] [Abstract][Full Text] [Related]
53. Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster.
McLean S; Rothman RB; Jacobson AE; Rice KC; Herkenham M
J Comp Neurol; 1987 Jan; 255(4):497-510. PubMed ID: 2880880
[TBL] [Abstract][Full Text] [Related]
54. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
55. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
[TBL] [Abstract][Full Text] [Related]
56. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
[TBL] [Abstract][Full Text] [Related]
57. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
[TBL] [Abstract][Full Text] [Related]
59. Structure-activity relationships of dynorphin a analogues modified in the address sequence.
Schlechtingen G; DeHaven RN; Daubert JD; Cassel JA; Chung NN; Schiller PW; Taulane JP; Goodman M
J Med Chem; 2003 May; 46(11):2104-9. PubMed ID: 12747782
[TBL] [Abstract][Full Text] [Related]
60. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
